Titan Pharmaceuticals (TTNP) Short Interest Ratio & Short Volume $4.03 +0.03 (+0.75%) (As of 11/4/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestTrends Titan Pharmaceuticals Short Interest DataTitan Pharmaceuticals (TTNP) has a short interest of 17,000 shares, representing 2.62% of the float (the number of shares available for trading by the public). This marks a -9.09% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 150,771 shares to cover all short positions.Current Short Interest17,000 sharesPrevious Short Interest18,700 sharesChange Vs. Previous Month-9.09%Dollar Volume Sold Short$80,070.00Short Interest Ratio0.0 Days to CoverLast Record DateOctober 15, 2024Outstanding Shares914,000 sharesFloat Size648,600 sharesShort Percent of Float2.62%Today's Trading Volume6,963 sharesAverage Trading Volume150,771 sharesToday's Volume Vs. Average5% Short Selling Titan Pharmaceuticals? Sign up to receive the latest short interest report for Titan Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTTNP Short Interest Over TimeTTNP Days to Cover Over TimeTTNP Percentage of Float Shorted Over Time Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Titan Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/202417,000 shares $80,070.00 -9.1%2.6%0 $4.71 9/30/202418,700 shares $98,549.00 -3.6%2.9%0 $5.27 9/15/202419,400 shares $107,476.00 +13.5%3.0%0 $5.54 8/31/202417,100 shares $104,823.00 +271.7%2.6%0 $6.13 8/15/20244,600 shares $23,092.00 +2.2%0.7%0 $5.02 7/31/20244,500 shares $26,235.00 -48.9%0.7%0.7 $5.83 Get the Latest News and Ratings for TTNP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Titan Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 7/15/20248,800 shares $40,920.00 -24.8%1.4%1.4 $4.65 6/30/202411,700 shares $65,169.00 +50.0%1.8%2.1 $5.57 6/15/20247,800 shares $54,132.00 -4.9%1.2%1.1 $6.94 5/31/20248,200 shares $53,383.64 -13.7%1.3%1.3 $6.51 5/15/20249,500 shares $60,800.00 -19.5%1.5%1.4 $6.40 4/30/202411,800 shares $79,119.00 +15.7%2.0%1.5 $6.71 4/15/202410,200 shares $74,023.44 +161.5%1.7%0.9 $7.26 3/31/20243,900 shares $27,924.00 -67.5%0.6%0.3 $7.16 3/15/202412,000 shares $112,920.00 -0.8%2.2%1.1 $9.41 2/29/202412,100 shares $90,750.00 +10.0%2.2%1.4 $7.50 2/15/202411,000 shares $74,800.00 +111.5%2.0%1.3 $6.80 1/31/20245,200 shares $29,952.00 +2.0%1.0%0.7 $5.76 1/15/20245,100 shares $32,742.00 +15.9%0.9%1.1 $6.42 12/31/20234,400 shares $36,300.00 -56.4%N/A1.2 $8.25 12/15/202310,100 shares $2,776.49 -87.3%N/A0.2 $0.27 11/30/202379,400 shares $27,790.00 -17.5%N/A2.1 $0.35 11/15/202396,200 shares $35,594.00 +3.4%N/A2.6 $0.37 10/31/202393,000 shares $37,246.50 +49.5%N/A2.5 $0.40 10/15/202362,200 shares $28,612.00 -12.4%N/A0.7 $0.46 9/30/202371,000 shares $33,654.00 -14.5%N/A0.8 $0.47 9/15/202383,000 shares $40,105.60 -6.3%N/A0.9 $0.48 8/31/202388,600 shares $45,451.80 -21.9%N/A1 $0.51 8/15/2023113,500 shares $61,063.00 -68.7%N/A1.3 $0.54 7/31/2023362,200 shares $222,028.60 +500.7%N/A4.3 $0.61 7/15/202360,300 shares $38,531.70 +24.3%N/A2.8 $0.64 6/30/202348,500 shares $31,340.70 -1.2%N/A2.6 $0.65 6/15/202349,100 shares $36,825.00 No ChangeN/A3.4 $0.75 5/31/202349,100 shares $37,512.40 +6.3%N/A3.5 $0.76 5/15/202346,200 shares $34,885.62 -26.1%N/A3.1 $0.76 4/30/202362,500 shares $48,731.25 +12.2%N/A4 $0.78 4/15/202355,700 shares $44,003.00 +24.1%N/A2.4 $0.79 3/31/202344,900 shares $37,267.00 +8.7%N/A1.8 $0.83 3/15/202341,300 shares $31,598.63 +4.0%N/A1.3 $0.77 2/28/202339,700 shares $37,016.28 -30.0%N/A1 $0.93Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW 2/15/202356,700 shares $54,035.10 -28.4%N/A1.4 $0.95 1/31/202379,200 shares $80,784.00 -16.3%N/A1.9 $1.02 1/15/202394,600 shares $87,296.88 -25.6%N/A2.5 $0.92 12/30/2022127,200 shares $99,610.32 -21.0%N/A3.7 $0.78 12/15/2022161,000 shares $143,290.00 -8.3%N/A5.1 $0.89 11/30/2022175,500 shares $142,506.00 -22.5%N/A5.5 $0.81 11/15/2022226,300 shares $217,859.01 +0.7%N/A6.5 $0.96 10/31/2022224,800 shares $224,800.00 -17.2%N/A4.6 $1.00 10/15/2022271,600 shares $274,316.00 -11.2%N/A4.3 $1.01 9/30/2022306,000 shares $330,480.00 -28.5%N/A3.6 $1.08 9/15/2022427,700 shares $560,287.00 -11.7%N/A0.8 $1.31 8/31/2022484,400 shares $639,408.00 +7.2%N/A0.8 $1.32 8/15/2022452,000 shares $687,040.00 -30.1%N/A0.7 $1.52 7/31/2022646,600 shares $853,512.00 +0.8%6.7%0.9 $1.32 7/15/2022641,800 shares $782,996.00 +77.2%6.7%0.8 $1.22 6/30/2022362,300 shares $202,453.24 -9.5%3.8%0.5 $0.56 6/15/2022400,200 shares $232,116.00 +263.2%N/A1.1 $0.58 5/31/2022110,200 shares $45,865.24 -40.5%N/A0.3 $0.42 5/15/2022185,300 shares $104,935.39 -1.6%N/A0.7 $0.57 4/30/2022188,300 shares $131,245.10 -40.9%N/A1.2 $0.70 4/15/2022318,400 shares $280,096.48 +15.8%N/A1.9 $0.88 3/31/2022275,000 shares $263,037.50 +1.1%N/A2 $0.96 3/15/2022272,100 shares $265,025.40 -17.3%N/A0.8 $0.97 2/28/2022328,900 shares $335,478.00 -2.9%N/A1.1 $1.02 2/15/2022338,800 shares $399,784.00 -6.0%N/A1.1 $1.18 1/31/2022360,300 shares $378,315.00 -9.9%N/A1.2 $1.05 1/15/2022399,700 shares $403,697.00 -15.5%N/A1.1 $1.01 12/31/2021473,100 shares $482,562.00 +44.9%N/A1.2 $1.02 12/15/2021326,600 shares $369,058.00 -3.1%N/A0.9 $1.13 11/30/2021336,900 shares $485,102.31 -19.7%N/A1.8 $1.44 11/15/2021419,700 shares $679,914.00 -7.8%N/A2.2 $1.62 10/29/2021455,000 shares $782,600.00 +20.3%N/A2.5 $1.72 10/15/2021378,200 shares $673,196.00 +57.3%N/A2.1 $1.78 9/30/2021240,400 shares $449,548.00 -6.0%N/A2.9 $1.87 9/15/2021255,700 shares $526,742.00 +39.1%N/A2.7 $2.06 8/31/2021183,800 shares $411,712.00 -36.3%1.9%1.8 $2.24 8/13/2021288,500 shares $628,930.00 -18.6%2.9%2.7 $2.18 7/30/2021354,200 shares $793,408.00 -12.3%3.6%3 $2.24 7/15/2021403,700 shares $924,473.00 -4.4%4.1%2.9 $2.29 6/30/2021422,400 shares $1.10 million -21.1%4.3%2.3 $2.60 6/15/2021535,400 shares $1.34 million -21.2%5.4%2.5 $2.50 5/28/2021679,500 shares $1.66 million -24.0%6.9%2.1 $2.44 5/14/2021894,200 shares $2.00 million -14.8%9.1%2 $2.24 4/30/20211,050,000 shares $2.63 million -13.2%10.7%1.1 $2.50 4/15/20211,210,000 shares $2.95 million -19.3%12.3%0.8 $2.44 3/31/20211,500,000 shares $4.28 million -2.6%15.2%0.9 $2.85 3/15/20211,540,000 shares $5.04 million -2.5%15.6%0.9 $3.27 2/26/20211,580,000 shares $5.28 million +20.6%16.0%0.9 $3.34 2/12/20211,310,000 shares $5.02 million +133.7%13.3%0.6 $3.83 1/29/2021560,500 shares $1.80 million +9.9%5.7%0.3 $3.22Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW 1/15/2021509,900 shares $1.78 million -15.1%5.2%0.3 $3.50 12/31/2020600,600 shares $1.95 million -28.1%8.5%0.4 $3.25 12/15/2020834,700 shares $2.74 million -95.0%11.8%0.6 $3.28 11/30/202016,600,000 shares $88.20 million +61.8%N/A11.8 $5.31 11/15/202010,260,000 shares $36.17 million -30.6%N/A0.3 $3.53 10/30/202014,790,000 shares $64.34 million +133.7%N/A0.9 $4.35 10/15/20206,330,000 shares $29.28 million -1.4%N/A1.2 $4.63 9/30/20206,420,000 shares $31.86 million -5.0%N/A1.4 $4.96 9/15/20206,760,000 shares $43.60 million -3.7%N/A1 $6.45 8/31/20207,020,000 shares $48.61 million +2.2%N/A1 $6.92 8/14/20206,870,000 shares $57.71 million -1.6%N/A0.7 $8.40 7/31/20206,980,000 shares $60.94 million -5.9%N/A0.6 $8.73 7/15/20207,420,000 shares $62.33 million -3.3%N/A0.6 $8.40 6/30/20207,670,000 shares $70.46 million -8.4%N/A0.6 $9.19 6/15/20208,370,000 shares $83.26 million +7.6%N/A0.7 $9.95 5/29/20207,780,000 shares $66.12 million -5.5%N/A0.7 $8.50 5/15/20208,230,000 shares $67.90 million +7.3%N/A0.6 $8.25 4/30/20207,670,000 shares $59.48 million +16.9%N/A0.6 $7.76 4/15/20206,560,000 shares $47.04 million -1.9%N/A0.6 $7.17 3/31/20206,690,000 shares $1.61 million -7.9%N/A0.4 $0.24 3/13/20207,264,700 shares $1.60 million +19.5%N/A0.2 $0.22 2/28/20206,080,000 shares $1.40 million +6.7%N/A0.4 $0.23 2/14/20205,700,000 shares $1.37 million +41.8%N/A0.5 $0.24 1/31/20204,020,000 shares $804,000.00 +22.6%N/A0.4 $0.20 1/15/20203,280,000 shares $754,400.00 +175.6%N/A0.3 $0.23 12/31/20191,190,000 shares $380,800.00 -52.8%N/A0.1 $0.32 TTNP Short Interest - Frequently Asked Questions What is Titan Pharmaceuticals' current short interest? Short interest is the volume of Titan Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of October 15th, traders have sold 17,000 shares of TTNP short. 2.62% of Titan Pharmaceuticals' shares are currently sold short. Learn More on Titan Pharmaceuticals' current short interest. What is a good short interest percentage for Titan Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.62% of Titan Pharmaceuticals' floating shares are currently sold short. Is Titan Pharmaceuticals' short interest increasing or decreasing? Titan Pharmaceuticals saw a drop in short interest in the month of October. As of October 15th, there was short interest totaling 17,000 shares, a drop of 9.1% from the previous total of 18,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Titan Pharmaceuticals' float size? Titan Pharmaceuticals currently has issued a total of 914,000 shares. Some of Titan Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Titan Pharmaceuticals currently has a public float of 648,600 shares. How does Titan Pharmaceuticals' short interest compare to its competitors? 2.62% of Titan Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Titan Pharmaceuticals: BioCardia, Inc. (1.84%), Longeveron Inc. (13.00%), NRx Pharmaceuticals, Inc. (7.18%), Avalo Therapeutics, Inc. (0.52%), Biora Therapeutics, Inc. (4.13%), Alzamend Neuro, Inc. (5.39%), ANEW Medical, Inc. (1.67%), Calidi Biotherapeutics, Inc. (7.72%), CERo Therapeutics Holdings, Inc. (1.07%), IN8bio, Inc. (0.46%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks. What does it mean to sell short Titan Pharmaceuticals stock? Short selling TTNP is an investing strategy that aims to generate trading profit from Titan Pharmaceuticals as its price is falling. TTNP shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Titan Pharmaceuticals? A short squeeze for Titan Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TTNP, which in turn drives the price of the stock up even further. How often is Titan Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TTNP, twice per month. The most recent reporting period available is October, 15 2024. More Short Interest Resources from MarketBeat Related Companies BioCardia Short Interest Longeveron Short Interest NRx Pharmaceuticals Short Interest Avalo Therapeutics Short Interest Biora Therapeutics Short Interest Alzamend Neuro Short Interest ANEW Medical Short Interest Calidi Biotherapeutics Short Interest CERo Therapeutics Short Interest IN8bio Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TTNP) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Titan Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Titan Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TTNP Stock Alerts